Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > There hmmm goes with that wonky math again.

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Mar 05, 2023 4:52pm

155 Views

Post# 35320219

RE:RE:RE:RE:There hmmm goes with that wonky math again.

If you knew your history and understood your investment you'd know that the Euphas abdominal Trial was halted at 64 patients for ethical reasons due to extremely good results ( could the same thing happen with Tigris?)

We agree on the pathetic pace of late.

I do not agree that nothing will be done to accelerate it.

This is something that is well within the power of the BoD to correct. As is IR and US investor visibility.

The AGM approacheth.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?